medigraphic.com

2011, Number 4

Next >>

Rev Med Inst Mex Seguro Soc 2011; 49 (4)

The problem of the venous thromboembolic disease in mexico

Majluf-Cruz A

Language: Spanish
References: 35
Page: 349-352
PDF size: 36.66 Kb.


ABSTRACT

It is necessary to spread the knowledge about the disease, however, venous thromboembolic guidelines published in this issue gives little attention to prevention, minimizes the evaluation of the risk factors, does not evaluate its impact on the non-surgical patient, and do not emphasize the benefits of non-pharmacological and extended thromboprophylaxis. Guidelines for clinical practice of the Instituto Mexicano del Seguro Social must suggest the way to attend patients at the lowest cost with quality. Because prevention is the best tool to fight VTD, these guidelines do not totally accomplish their institutional objectives.


REFERENCES

  1. Piazza G, Goldhaber SZ. Acute pulmonary embolism: part I. Epidemiology and diagnosis. Circulation 2006;114: e28-e32.

  2. Linblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 1991;302(6778)709-711.

  3. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989;82(4):203-205.

  4. Alikhan R, Peters F, Wilmott R, Cohen AT. Fatal pulmonary embolism in hospitalized patients: a necropsy review. J Clin Pathol 2004;57(12):1254-1257.

  5. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism. American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th edition). Chest 2008;133(6 Suppl):381S-453S.

  6. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Arch Intern Med 1991;151(5):933-938.

  7. Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997;82(4)423-428.

  8. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125(1):1-7.

  9. Pengo V, Lensing AW, Prins MH, et al; Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350(22):2257-2264.

  10. Anderson FA Jr, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 2007;82(9):777-782.

  11. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemost 2007;98(4):756-764.

  12. Kakkar VV, Corrigan TP, Fossard DP, Sutherland I, Shelton MG, Thirlwall J. Prevention of fatal postoperative pulmonary embolism by low doses of heparin: an international multicenter trial. Lancet 1975;2(7924):45-51.

  13. Nicolaides AN, Fareed J, Kakkar AK, Breddin HK, Goldhaber SZ, Hull R, et al. Prevention and treatment of venous thromboembolism international consensus statement (guidelines according to scientific evidence). Int Angiol 2006;25(2):101-161.

  14. Cohen AT, Alikhan R, Arcelus JI, et al. Assessment of venous thromboembolism risk and the benefits of thrombo-prophylaxis in medical patients. Thromb Haemost 2005;94 (4):750- 759.

  15. Francis CW. Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med 2007;356:1438-1444.

  16. Haas SK. Venous thromboembolic risk and its prevention in hospitalized medical patients. Semin Thromb Haemost 2002;28:577-583.

  17. Monreal M, Kakkar AK, Caprini JA, Barba R, Uresandi F, Valle R, et al. The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients: findings from the RIETE registry. J Thromb Haemost 2004;2:1892-1898.

  18. Spyropoulos AC. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. Chest 2005;128:958-969.

  19. Kahn SR, Panju A, Geerts W, Pineo GF, Desjardins L, Turpie AG, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 2007;119:145-155.

  20. Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the international medical prevention registry on venous thromboembolism. Chest 2007;132:936-945.

  21. Stein PD, Beemath A, Olson RE. Trends in the incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients. Am J Cardiol 2005;95:1525-1526.

  22. Piazza G, Seddighzadeh A, Goldhaber SZ. Double trouble for 2609 hospitalized medical patients who developed deep vein thrombosis. Prophylaxis omitted more often and pulmonary embolism more frequent. Chest 2007;132:554-561.

  23. Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals’compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm 2007;64:69-76.

  24. Pini M, Froehlich J, Bergmann JF, Monreal M, Piovella F, Huang W, et al. Comparison of US and European practices in the prevention of venous thromboembolism in hospitalized medical patients: findings from the international medical prevention registry on venous thromboembolism (IMPROVE). Blood 2003;102:1151.

  25. Baglin T, Barrowcliffe TW, Cohen A, Greaves M; British Committee for Standards in Haematology. Guidelines on the use and monitoring of heparin. Br J Haematol 2006; 133:19-34.

  26. Samama MM, Cohen AT, Darmon JY; Prophylaxis in Medical Patients with Enoxaparin Study Group, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999;341(11):793-800.

  27. Cohen AT, Davidson BL, Gallus AS et al; ARTEMIS Investigators. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial. BMJ 2006; 332(7535):325-329.

  28. Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004;164(9):963-968.

  29. Monreal M, Suárez C, Fajardo JA, Barba R, Uresandi F, Valle R, et al. Management of patients with acute venous thromboembolism: findings from the RIETE registry. Pathophysiol Haemost Thromb 2003;33(5-6):330-334.

  30. Wells PS, Lensing AW, Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism: a meta-analysis. Arch Intern Med 1994;154(1): 67-72.

  31. Urbankova J, Quiroz R, Kucher N, Goldhaber SZ. Intermittent pneumatic compression and deep vein thrombosis prevention: a meta-analysis in postoperative patients. Thromb Haemost 2005; 94(6):1181-1185.

  32. Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev (database online). Issue 3, 2000.

  33. Agu O, Hamilton G, Baker D. Graduated compression stockings in the prevention of venous thromboembolism. Br J Surg 1999;86:992-1004.

  34. Limpus A, Chaboyer W, McDonald E, Thalib L. Mechanical thromboprophylaxis in critically ill patients: a systematic review and meta-analysis. Am J Crit Care 2006;15:402-410.

  35. Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch Intern Med 2007;167(14):1471-1475.




2020     |     www.medigraphic.com